Subtopic Deep Dive
Terminalia chebula Anticancer Activity
Research Guide
What is Terminalia chebula Anticancer Activity?
Terminalia chebula anticancer activity refers to the pharmacological effects of extracts and compounds from Terminalia chebula, such as chebulagic acid, in inducing apoptosis, G1 cell cycle arrest, and inhibiting NFκB in cancer cell lines.
Research demonstrates Terminalia chebula's bioactive fractions promote keratinocyte and fibroblast proliferation while exhibiting cytotoxic effects in retinoblastoma cells (Singh et al., 2014, 46 citations). Chebulagic acid specifically causes G1 arrest and apoptosis (Kumar et al., 2014, 40 citations). Studies span ethnopharmacology to in vitro assays, with approximately 10 key papers from provided lists.
Why It Matters
Terminalia chebula offers low-toxicity plant-derived leads for oncology, as chebulagic acid inhibits NFκB and induces apoptosis in retinoblastoma cells (Kumar et al., 2014). Extracts show dual roles in wound healing via cell proliferation (Singh et al., 2014) and potential anticancer activity alongside hepatoprotection (Adhvaryu, 2007). These properties support development of herbal chemotherapeutics in Ayurveda, used by over 70% of India's population (Vaidya and Devasagayam, 2007).
Key Research Challenges
Bioactive Compound Isolation
Fractionating Terminalia chebula extracts to isolate pure chebulagic acid or gallotannins remains challenging due to complex polyphenols. Variability in plant sourcing affects reproducibility (Kunwar et al., 2010). In vitro results need validation in animal models (Singh et al., 2014).
Mechanism Elucidation
Linking chebulagic acid to NFκB inhibition and G1 arrest requires advanced proteomics (Kumar et al., 2014). Few studies quantify dose-response in diverse cancer lines. Clinical translation lags behind ethnopharmacological evidence (Vaidya and Devasagayam, 2007).
Toxicity Profiling
Balancing anticancer cytotoxicity with safety in normal cells, as seen in fibroblast assays, demands comprehensive profiling (Singh et al., 2014). Hepatoprotective effects may confound dosing (Adhvaryu, 2007). Standardization across formulations is inconsistent (Kunwar et al., 2010).
Essential Papers
Traditional herbal medicine in Far-west Nepal: a pharmacological appraisal
Ripu M. Kunwar, Keshab Shrestha, Rainer W. Bussmann · 2010 · Journal of Ethnobiology and Ethnomedicine · 505 citations
Abstract Background Plant species have long been used as principal ingredients of traditional medicine in far-west Nepal. The medicinal plants with ethnomedicinal values are currently being screene...
Current Status of Herbal Drugs in India: An Overview
Ashok Vaidya, T.P.A. Devasagayam · 2007 · Journal of Clinical Biochemistry and Nutrition · 287 citations
Herbal drugs constitute a major share of all the officially recognised systems of health in India viz. Ayurveda, Yoga, Unani, Siddha, Homeopathy and Naturopathy, except Allopathy. More than 70% of ...
Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment
Jogender Mehla, Pooja Gupta, Monika Pahuja et al. · 2020 · Brain Sciences · 94 citations
Cognitive impairment, associated with ageing, stress, hypertension and various neurodegenerative disorders including Parkinson’s disease and epilepsy, is a major health issue. The present review fo...
Genus <i>Tinospora</i>: Ethnopharmacology, Phytochemistry, and Pharmacology
Sen-Sen Chi, Gaimei She, Dan Han et al. · 2016 · Evidence-based Complementary and Alternative Medicine · 77 citations
The genus Tinospora includes 34 species, in which several herbs were used as traditional medicines by indigenous groups throughout the tropical and subtropical parts of Asia, Africa, and Australia....
Effects of four Indian medicinal herbs on Isoniazid-, Rifampicin- and Pyrazinamide-induced hepatic injury and immunosuppression in guinea pigs
Meghna R Adhvaryu · 2007 · World Journal of Gastroenterology · 75 citations
All four herbs showed hepatoprotective potential and prevented immunosuppression. CL and TC showed the highest hepatoprotective activity, while TC and ZM showed strong immunostimulatory activity.
Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening
Saranya Nallusamy, Jayakanthan Mannu, Caroline Ravikumar et al. · 2021 · Frontiers in Pharmacology · 72 citations
Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) being a causative agent for global pandemic disease nCOVID’19, has acquired much scientific attention for the development of effective ...
Therapeutic opportunities of edible antiviral plants for COVID-19
Bhoomika M. Patel, Supriya Sharma, Nisha Nair et al. · 2021 · Molecular and Cellular Biochemistry · 62 citations
Reading Guide
Foundational Papers
Start with Kunwar et al. (2010, 505 citations) for ethnopharmacological context of Terminalia chebula; then Singh et al. (2014, 46 citations) for extract effects on cells; Kumar et al. (2014, 40 citations) details chebulagic acid mechanisms.
Recent Advances
Majoumouo et al. (2020, 58 citations) on biogenic gold nanoparticles from related Terminalia species; focus on cytotoxic evaluations linking to anticancer potential.
Core Methods
In vitro cytotoxicity assays (MTT on L929 fibroblasts, keratinocytes); apoptosis detection (NFκB inhibition, G1 arrest via flow cytometry); extract fractionation (organic/aqueous solvents).
How PapersFlow Helps You Research Terminalia chebula Anticancer Activity
Discover & Search
Research Agent uses searchPapers and exaSearch to find Terminalia chebula studies, then citationGraph on 'Chebulagic acid from Terminalia chebula causes G1 arrest...' (Kumar et al., 2014) reveals 40+ citing papers on apoptosis mechanisms, while findSimilarPapers uncovers related ethnopharmacology works like Kunwar et al. (2010).
Analyze & Verify
Analysis Agent applies readPaperContent to extract chebulagic acid mechanisms from Kumar et al. (2014), verifies claims with CoVe chain-of-verification against 250M+ OpenAlex papers, and runs PythonAnalysis to plot dose-response curves from Singh et al. (2014) fibroblast data using matplotlib for statistical validation (GRADE: B for in vitro evidence).
Synthesize & Write
Synthesis Agent detects gaps in clinical trials for Terminalia chebula via contradiction flagging across Adhvaryu (2007) and Kumar (2014), generates exportMermaid diagrams of apoptosis pathways; Writing Agent uses latexEditText, latexSyncCitations for 10-paper review, and latexCompile to produce oncology manuscript drafts.
Use Cases
"Extract and plot IC50 values for Terminalia chebula extracts from cancer cell assays."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Singh et al., 2014; Kumar et al., 2014) → runPythonAnalysis (pandas data extraction, matplotlib IC50 plots) → researcher gets CSV-exported dose-response graphs with stats.
"Draft LaTeX review on chebulagic acid apoptosis induction."
Synthesis Agent → gap detection → Writing Agent → latexEditText (add sections) → latexSyncCitations (Kunwar 2010 et al.) → latexCompile → researcher gets compiled PDF with figure tables on G1 arrest.
"Find code for Terminalia chebula nanoparticle synthesis analysis."
Research Agent → paperExtractUrls (Majoumouo et al., 2020) → paperFindGithubRepo → githubRepoInspect → researcher gets annotated nanoparticle cytotoxicity scripts linked to gold NP evaluations.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (Terminalia chebula anticancer) → citationGraph → DeepScan (7-step: readPaperContent → CoVe → runPythonAnalysis on 20+ papers) → structured report on chebulagic acid efficacy. Theorizer generates hypotheses on NFκB pathways from Kumar (2014) + Singh (2014). DeepScan verifies wound healing vs. anticancer duality with GRADE scoring.
Frequently Asked Questions
What defines Terminalia chebula anticancer activity?
It encompasses apoptosis induction and G1 arrest by chebulagic acid in retinoblastoma cells (Kumar et al., 2014) and cytotoxic effects in cell lines from extracts (Singh et al., 2014).
What methods study this activity?
In vitro assays on keratinocytes, fibroblasts (Singh et al., 2014), and retinoblastoma cells measure proliferation and apoptosis; ethnopharmacological surveys document traditional use (Kunwar et al., 2010).
What are key papers?
Foundational: Kumar et al. (2014, 40 citations) on chebulagic acid; Singh et al. (2014, 46 citations) on cell proliferation. Ethnopharmacology: Kunwar et al. (2010, 505 citations); Adhvaryu (2007, 75 citations).
What open problems exist?
Clinical trials lacking; bioactive standardization needed (Vaidya and Devasagayam, 2007); in vivo validation of NFκB inhibition beyond retinoblastoma (Kumar et al., 2014).
Research Phytochemicals and Medicinal Plants with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Terminalia chebula Anticancer Activity with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers